# Héctor M. García‐García

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hector-m-garcia-garcia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,103 |
| Field | Coronary Interventions and Diagnostics |
| h-index | 69 |
| i10-index | 252 |
| Last Known Institution | MedStar Health |
| OpenAlex ID | https://openalex.org/A5081547954 |
| ORCID iD | https://orcid.org/0000-0001-5100-0471 |
| Works | 644 |

## Researcher papers

- [Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document](https://scholariq.org/papers/standardized-end-point-definitions-for-coronary-intervention-trials-the-academic/)
- [Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II](https://scholariq.org/papers/anatomical-and-clinical-characteristics-to-guide-decision-making-between/)
- [A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods](https://scholariq.org/papers/a-bioabsorbable-everolimus-eluting-coronary-stent-system-absorb-2-year-outcomes/)
- [A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial](https://scholariq.org/papers/a-bioabsorbable-everolimus-eluting-coronary-stent-system-for-patients-with/)
- [A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial](https://scholariq.org/papers/a-bioresorbable-everolimus-eluting-scaffold-versus-a-metallic-everolimus-eluting/)
- [Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis](https://scholariq.org/papers/evaluation-of-the-second-generation-of-a-bioresorbable-everolimus-eluting/)
- [Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study](https://scholariq.org/papers/identification-of-patients-and-plaques-vulnerable-to-future-coronary-events-with/)
- [Optical coherence tomography in coronary atherosclerosis assessment and intervention](https://scholariq.org/papers/optical-coherence-tomography-in-coronary-atherosclerosis-assessment-and/)

## Researcher topics

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)

## Researcher university

- [MedStar Health](https://scholariq.org/institutions/medstar-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.